150 related articles for article (PubMed ID: 18360054)
1. Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.
Liao Y; Zhao H; Ogai A; Kato H; Asakura M; Kim J; Asanuma H; Minamino T; Takashima S; Kitakaze M
Hypertens Res; 2008 Feb; 31(2):335-44. PubMed ID: 18360054
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.
Zhao H; Liao Y; Minamino T; Asano Y; Asakura M; Kim J; Asanuma H; Takashima S; Hori M; Kitakaze M
Hypertens Res; 2008 Oct; 31(10):1977-87. PubMed ID: 19015605
[TBL] [Abstract][Full Text] [Related]
3. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
[TBL] [Abstract][Full Text] [Related]
4. Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Asanuma H; Minamino T; Tomoike H; Hori M; Kitakaze M
Cardiovasc Res; 2005 Mar; 65(4):879-88. PubMed ID: 15721868
[TBL] [Abstract][Full Text] [Related]
5. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
Liao Y; Takashima S; Asano Y; Asakura M; Ogai A; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Ogita H; Tomoike H; Hori M; Kitakaze M
Circ Res; 2003 Oct; 93(8):759-66. PubMed ID: 12970111
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine ameliorates myocardial hypertrophy by inhibiting EGFR phosphorylation.
Liao Y; Asakura M; Takashima S; Kato H; Asano Y; Shintani Y; Minamino T; Tomoike H; Hori M; Kitakaze M
Biochem Biophys Res Commun; 2005 Feb; 327(4):1083-7. PubMed ID: 15652507
[TBL] [Abstract][Full Text] [Related]
7. Antihypertrophic effects of adiponectin on cardiomyocytes are associated with the inhibition of heparin-binding epidermal growth factor signaling.
Liao Y; Xuan W; Zhao J; Bin J; Zhao H; Asakura M; Funahashi T; Takashima S; Kitakaze M
Biochem Biophys Res Commun; 2010 Mar; 393(3):519-25. PubMed ID: 20152812
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats.
Kang L; Ge CJ; Hu SJ
Pharmacology; 2007; 80(2-3):120-6. PubMed ID: 17534121
[TBL] [Abstract][Full Text] [Related]
10. Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects.
Schmechel A; Grimm M; El-Armouche A; Höppner G; Schwoerer AP; Ehmke H; Eschenhagen T
Cardiovasc Res; 2009 Apr; 82(1):100-6. PubMed ID: 19136528
[TBL] [Abstract][Full Text] [Related]
11. Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice.
Zou Y; Lin L; Ye Y; Wei J; Zhou N; Liang Y; Gong H; Li L; Wu J; Li Y; Jia Z; Wu Y; Zhou J; Ge J
J Cardiovasc Pharmacol; 2012 Mar; 59(3):268-80. PubMed ID: 22075750
[TBL] [Abstract][Full Text] [Related]
12. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
[TBL] [Abstract][Full Text] [Related]
15. Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat.
Garjani A; Andalib S; Biabani S; Soraya H; Doustar Y; Garjani A; Maleki-Dizaji N
Eur J Pharmacol; 2011 Sep; 666(1-3):135-41. PubMed ID: 21570962
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats.
Akahori H; Tsujino T; Naito Y; Matsumoto M; Sasaki N; Iwasaku T; Eguchi A; Sawada H; Hirotani S; Masuyama T
J Hypertens; 2014 Jul; 32(7):1534-41; discussion 1541. PubMed ID: 24759122
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
18. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
Beckles DL; Mascareno E; Siddiqui MA
Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
